デフォルト表紙
市場調査レポート
商品コード
1754079

口内炎治療市場レポート:剤形、薬剤クラス、適応症、地域別、2025-2033年

Mouth Ulcer Treatment Market Report by Formulation, Drug Class, Indication, and Region 2025-2033


出版日
発行
IMARC
ページ情報
英文 149 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.06円
口内炎治療市場レポート:剤形、薬剤クラス、適応症、地域別、2025-2033年
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

口内炎治療の世界市場規模は2024年に19億7,000万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに25億5,000万米ドルに達し、2025年から2033年にかけて2.74%の成長率(CAGR)を示すと予測しています。同市場は、主に口腔衛生問題の発生率の上昇、治療オプションに対する意識の高まり、市販治療薬に対する需要の高まりによって大きな成長を遂げています。医薬製剤の進歩、ヘルスケアへのアクセスの拡大、口内炎治療のための即効性鎮痛剤に対する消費者の嗜好も市場成長にプラスに寄与しています。

口内炎治療市場分析:

  • 主な市場促進要因:主な市場促進要因としては、アフタ性潰瘍のような口腔衛生問題の有病率の増加、利用可能な治療法に関する認知度の上昇、市販治療薬に対する需要の高まりなどが挙げられます。人口の高齢化、ストレスなどの生活習慣関連疾患の増加、食生活の乱れなどが口内炎の増加に寄与しています。痛みを和らげるジェル、トローチ、マウスウォッシュなどの医薬品製剤の進歩が、市場の成長をさらに後押ししています。ヘルスケアへのアクセスの拡大や、迅速かつ効果的な治療オプションに対する消費者の嗜好の高まりも、口内炎治療に対する世界の需要を促進する重要な要因となっています。
  • 主な市場動向:主な市場動向としては、消費者がより安全で副作用のない治療法を求めるようになり、自然療法やハーブ療法へのシフトが進んでいることが挙げられます。また、即効性のあるジェルや溶解可能なパッチなど、革新的な製剤の開発も人気を集めています。eコマースの成長に牽引された、一般用医薬品(OTC)のオンライン販売の増加も注目すべき動向です。さらに市場は、鎮痛、治癒、予防を提供する多機能製品への需要の高まりを目の当たりにしています。製薬会社は、さまざまなタイプの潰瘍に対応する治療法の開発にますます力を入れるようになっており、それによって製品の有効性とユーザーの利便性の両方を高めています。
  • 地理的動向:市場の地理的動向は、北米と欧州の著しい成長を示しています。これは、高いヘルスケア意識、高度な医療インフラ、市販品の入手可能性などが背景にあります。アジア太平洋地域は、ヘルスケアへのアクセスの向上、口内炎の発生率の増加、治療に対する消費者の意識の高まりにより、市場が急速に拡大しています。インドや中国のような国々では、人口の多さと医療サービスの向上に後押しされ、従来の治療法とハーブ療法の両方に対する需要が増加しています。一方、中東・アフリカ地域では、他の地域と比較して成長は鈍化しているもの、より先進的な治療法が徐々に採用されつつあります。
  • 競合情勢:口内炎治療業界の主要市場企業には、Blistex Inc.、Church &Dwight Co., Inc.、3M Company、Colgate-Palmolive Company、GSK plc.、Bristol-Myers Squibb Company、Pfizer Inc.などが含まれます。
  • 課題と機会:市場は、新興国市場における効果的な治療法の認知度の低さ、一部の医薬品に伴う副作用、在宅治療などの代替療法との競合など、さまざまな課題に直面しています。また、規制上のハードルや新製剤の厳しい承認プロセスも、市場関係者にとっての課題となっています。しかし、消費者により安全性が高いと認識されている自然療法やハーブ療法への需要の高まりには、大きなビジネスチャンスが存在します。新興国市場におけるヘルスケアへのアクセスの拡大や、より効果的で即効性のある治療を生み出すための研究開発への投資の増加も、この分野の成長の可能性をもたらしています。

口内炎治療市場動向:

製剤イノベーション

各社は、迅速な緩和と治癒を求める消費者の需要に対応するため、即効性のある口内炎治療薬を開発しています。これらのイノベーションには、痛みを最小限に抑え、数時間以内に回復を早めるように設計された局所用ジェル、口腔洗浄剤、薬用パッチなどが含まれます。先進的な製剤は、即時吸収または徐放性による標的作用の提供に重点を置いており、効果が長時間持続します。この動向は、消費者の利便性への期待に後押しされたもので、塗布が容易でありながら迅速な緩和をもたらす製品が求められています。処方箋を必要としない迅速な治療が高く評価される多忙なライフスタイルにおいても、こうした迅速な解決策は魅力的です。さらに、2024年のEuropean Journal of Pharmaceutics and Biopharmaceutics誌に掲載された論文によると、革新的なオイゲノールとホウ砂をベースとした口腔内分散性フィルム(ODF)の開発は、口内炎を含む口腔疾患を治療する従来の方法に代わる、はるかに効率的な結果をもたらす好ましい選択肢として浮上しています。ODFは、超薄型で、スタンプサイズで、携帯可能で、患者に優しく、親水性のフィルムであり、水や嚥下を必要とせず、舌や頬の上で数秒で溶解・崩壊します。この投与法は、特に小児、老人、嚥下障害のある特殊な患者層に普及しています。

eコマースチャネルの成長

より多くの消費者が利便性を求めてオンラインショッピングに移行しているため、口内炎治療のeコマースチャネルの成長は加速しています。オンラインプラットフォームでは、地元の薬局では手に入らないような様々な天然薬、OTC薬、特殊な治療薬など、幅広い品揃えを提供しています。消費者は、価格の比較、レビューの閲覧、製品の迅速な受け取りが容易で、多くの場合、割引や定期購入サービスが受けられるという利点があります。さらに、電子薬局やデジタルヘルスプラットフォームの台頭は、これらの治療法の入手可能性とアクセシビリティの向上に貢献し、市場におけるオンライン販売を後押ししています。例えば、IMARCによると、世界の電子薬局市場規模は2023年に942億米ドルに達しました。今後、IMARCグループは、同市場が2032年までに3,141億米ドルに達し、2024年から2032年の間に14.32%の成長率(CAGR)を示すと予測しています。さらに、アマゾンファーマシーは2024年6月、メディケア保険の加入者にも定期購入サービスを拡大する意向であることを発表しました。この拡大により、5,000万人以上のメディケア受給者がAmazon Pharmacyの定額処方サービスであるRxPassを利用できるようになります。

ナチュラル&ハーブ製品へのシフト

消費者は、合成薬の潜在的な副作用に対する懸念から、口内炎治療のために天然素材やハーブ製品にますます目を向けるようになっています。アロエベラ、カモミール、甘草のような成分は、鎮静作用や治癒作用があるとして好まれています。このような変化は、人々が健康志向のライフスタイルに沿った、オーガニックで化学物質を含まないソリューションを好むようになり、ウェルネスに広く焦点が当てられるようになったことが背景にあります。このような治療に対する需要の高まりは、この傾向に対応した植物由来の製品を開発する企業を後押しし、天然代替品が広く市場に出回るようになっています。口内炎治療市場概要によると、このような自然療法やハーブ療法に対する消費者の嗜好の高まりは、オーガニックで化学物質を含まないソリューションに対する需要の高まりに対応するため、より多くの企業が植物ベースの製剤に投資することで、大きな成長を促進すると予想されています。例えば、2023年11月、UGM歯学部の学生が口内炎治療のために果物の皮からエコ酵素を開発したと発表しました。研究チームは、さまざまな果物や植物の皮をエコ酵素に加工し、口内炎の治癒促進を目指しました。ラットを使った実験室調査では、エコ酵素パッチが口内炎の傷の炎症細胞を減少させるという有望な結果が得られました。研究は初期段階にあり、動物実験にとどまっているが、人間への使用の安全性と有効性を確保するためには、さらなる包括的な研究が必要です。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の口内炎治療市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場内訳:剤形別
  • 市場内訳:薬剤クラス別
  • 市場内訳:適応症別
  • 市場内訳:地域別
  • 市場予測
  • SWOT分析
  • バリューチェーン分析
  • ポーターのファイブフォース分析

第6章 市場内訳:剤形別

  • ゲル
  • スプレー
  • マウスウォッシュ
  • トローチ

第7章 市場内訳:薬剤クラス別

  • コルチコステロイド
  • 麻酔薬
  • 鎮痛剤
  • 抗菌剤
  • 抗ヒスタミン薬

第8章 市場内訳:適応症別

  • アフタ性口内炎
  • 口腔扁平苔癬
  • その他

第9章 市場内訳:地域別

  • 北米
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ
  • ラテンアメリカ

第10章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Blistex Inc.
    • Church & Dwight Co., Inc.
    • 3M Company
    • Colgate-Palmolive Company
    • GSK plc.
    • Bristol-Myers Squibb Company
    • Pfizer Inc.
図表

List of Figures

  • Figure 1: Global: Mouth Ulcer Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Mouth Ulcer Treatment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Mouth Ulcer Treatment Market: Breakup by Formulation (in %), 2024
  • Figure 4: Global: Mouth Ulcer Treatment Market: Breakup by Drug Class (in %), 2024
  • Figure 5: Global: Mouth Ulcer Treatment Market: Breakup by Indication (in %), 2024
  • Figure 6: Global: Mouth Ulcer Treatment Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Mouth Ulcer Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 8: Global: Mouth Ulcer Treatment Industry: SWOT Analysis
  • Figure 9: Global: Mouth Ulcer Treatment Industry: Value Chain Analysis
  • Figure 10: Global: Mouth Ulcer Treatment Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Mouth Ulcer Treatment (Gel) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Mouth Ulcer Treatment (Gel) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Mouth Ulcer Treatment (Spray) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Mouth Ulcer Treatment (Spray) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Mouth Ulcer Treatment (Mouthwash) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Mouth Ulcer Treatment (Mouthwash) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Mouth Ulcer Treatment (Lozenges) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Mouth Ulcer Treatment (Lozenges) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Mouth Ulcer Treatment (Corticosteroids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Mouth Ulcer Treatment (Corticosteroids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Mouth Ulcer Treatment (Anesthetics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Mouth Ulcer Treatment (Anesthetics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Mouth Ulcer Treatment (Analgesics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Mouth Ulcer Treatment (Analgesics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Mouth Ulcer Treatment (Antimicrobials) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Mouth Ulcer Treatment (Antimicrobials) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Mouth Ulcer Treatment (Antihistamines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Mouth Ulcer Treatment (Antihistamines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Mouth Ulcer Treatment (Aphthous Stomatitis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Mouth Ulcer Treatment (Aphthous Stomatitis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Mouth Ulcer Treatment (Oral Lichen Planus) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Mouth Ulcer Treatment (Oral Lichen Planus) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Mouth Ulcer Treatment (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Mouth Ulcer Treatment (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: North America: Mouth Ulcer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: North America: Mouth Ulcer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Europe: Mouth Ulcer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Europe: Mouth Ulcer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Asia Pacific: Mouth Ulcer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Asia Pacific: Mouth Ulcer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Middle East and Africa: Mouth Ulcer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Middle East and Africa: Mouth Ulcer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Latin America: Mouth Ulcer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Latin America: Mouth Ulcer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033

List of Tables

  • Table 1: Global: Mouth Ulcer Treatment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Mouth Ulcer Treatment Market Forecast: Breakup by Formulation (in Million USD), 2025-2033
  • Table 3: Global: Mouth Ulcer Treatment Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
  • Table 4: Global: Mouth Ulcer Treatment Market Forecast: Breakup by Indication (in Million USD), 2025-2033
  • Table 5: Global: Mouth Ulcer Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Mouth Ulcer Treatment Market: Competitive Structure
  • Table 7: Global: Mouth Ulcer Treatment Market: Key Players
目次
Product Code: SR112025A1101

The global mouth ulcer treatment market size reached USD 1.97 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.55 Billion by 2033, exhibiting a growth rate (CAGR) of 2.74% during 2025-2033. The market is experiencing significant growth mainly driven by rising incidences of oral health issues, an increased awareness of treatment options and the growing demand for over-the-counter remedies. Advancements in pharmaceutical formulations, expanding healthcare access and consumer preference for fast-acting, pain-relief products to treat mouth ulcers are also contributing positively to the market growth.

Mouth Ulcer Treatment Market Analysis:

  • Major Market Drivers: Key market drivers include the increasing prevalence of oral health issues like aphthous ulcers, rising awareness about available treatments, and the growing demand for over-the-counter remedies. The aging population, higher incidences of lifestyle-related conditions such as stress, and poor dietary habits contribute to the rise in mouth ulcers. Advancements in pharmaceutical formulations, including pain-relief gels, lozenges, and mouthwashes, are further fueling the market growth. Expanding access to healthcare and the growing consumer preference for quick, effective treatment options are also acting as significant factors driving the demand for mouth ulcer treatments globally.
  • Key Market Trends: Key market trends include a growing shift toward natural and herbal remedies as consumers seek safer, side-effect-free treatments. The development of innovative formulations, such as fast-acting gels and dissolvable patches, is also gaining traction. Increased online sales of over-the-counter (OTC) treatments, driven by e-commerce growth, is another notable trend. Furthermore, the market is witnessing a rise in the demand for multi-functional products that offer pain relief, healing, and prevention. Pharmaceutical companies are increasingly focusing on developing treatments that cater to various types of ulcers, thereby enhancing both product efficacy and convenience for users.
  • Geographical Trends: Geographical trends in the market shows significant growth in North America and Europe, driven by high healthcare awareness, advanced medical infrastructure, and the availability of over-the-counter products. The Asia-Pacific region is experiencing rapid market expansion due to rising healthcare access, increasing incidences of mouth ulcers, and growing consumer awareness about treatments. Countries like India and China are seeing an increased demand for both conventional and herbal remedies, fueled by large populations and improved healthcare services. In contrast, the Middle East and Africa region is gradually adopting more advanced treatments, though growth remains slower as compared to other regions.
  • Competitive Landscape: Some of the major market players in the mouth ulcer treatment industry include Blistex Inc, Church & Dwight Co. Inc., 3M Company, Colgate-Palmolive Company, GSK plc., Bristol-Myers Squibb Company, and Pfizer Inc., among many others.
  • Challenges and Opportunities: The market faces various challenges including the limited awareness of effective treatments in developing regions, the side effects associated with some pharmaceutical products, and competition from alternative remedies like home-based treatments. Regulatory hurdles and stringent approval processes for new formulations also pose challenges for market players. However, significant opportunities exist in the growing demand for natural and herbal remedies, which are perceived as safer by consumers. Expanding healthcare access in emerging markets and increasing investments in research and development to create more effective, fast-acting treatments also offer potential for growth in this sector.

Mouth Ulcer Treatment Market Trends:

Innovation in Formulations

Companies are developing fast-acting mouth ulcer treatments to address the consumer demand for quicker relief and healing. These innovations include topical gels, oral rinses, and medicated patches designed to minimize pain and accelerate recovery within hours. Advanced formulations focus on delivering targeted action through immediate absorption or sustained release, providing long-lasting effects. This trend is driven by consumer expectations for convenience, with products that offer swift relief while being easy to apply. These rapid solutions are also appealing in busy lifestyles where quick treatment without the need for prescriptions is highly valued. Furthermore, according to an article published in the European Journal of Pharmaceutics and Biopharmaceutics in 2024, the development of innovative eugenol and borax-based orodispersible films (ODFs) have emerged as the preferred alternative to traditional methods of treating oral diseases, including mouth ulcers, with a much more efficient results. ODFs are ultra-thin, stamp-sized, portably-used, patient-friendly, and hydrophilic films that dissolve and disintegrate within seconds on the tongue or buccal area without the need of water or swallowing. This administration is particularly prevalent among pediatric, geriatric, and special patient populations who have dysphagia.

Growth in E-Commerce Channels

Growth in e-commerce channels for mouth ulcer treatments is accelerating as more consumers shift toward online shopping for convenience. Online platforms offer a wider selection of products, including various natural, OTC, and specialized treatments, which may not be available in local pharmacies. Consumers benefit from the ease of comparing prices, reading reviews, and receiving products quickly, often with discounts or subscription services. Additionally, the rise of e-pharmacies and digital health platforms has contributed to the increased availability and accessibility of these treatments, boosting online sales in the market. For instance, according to IMARC, the global e-pharmacy market size reached US$ 94.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 314.1 Billion by 2032, exhibiting a growth rate (CAGR) of 14.32% during 2024-2032. Furthermore, Amazon Pharmacy announced in June 2024 that it intends to expand its subscription service to enrollees of Medicare insurance plans. The expansion will be available to more than 50 million Medicare beneficiaries, who will have access to RxPass, Amazon Pharmacy's subscription prescription service

Shift Towards Natural and Herbal Products

Consumers are increasingly turning to natural and herbal products for mouth ulcer treatment due to concerns about the potential side effects of synthetic medications. Ingredients like aloe vera, chamomile, and licorice are favored for their soothing and healing properties. This shift is driven by a broader focus on wellness, as people prefer organic and chemical-free solutions that align with health-conscious lifestyles. The growing demand for such treatments is encouraging companies to develop more plant-based products that cater to this trend, making natural alternatives widely available across the market. According to the mouth ulcer treatment market overview, this rising consumer preference for natural and herbal remedies is expected to drive significant growth, with more companies investing in plant-based formulations to meet the increasing demand for organic, chemical-free solutions. For instance, in November 2023, UGM Dentistry students announced the development of eco-enzymes from fruit peels for mouth ulcer treatment. The team processed peels from various fruits and plants into eco-enzymes, aiming to accelerate mouth ulcer healing. Laboratory research on rats showed promising results, with the eco-enzyme patch reducing inflammatory cells in mouth ulcer wounds. While the research is in early stages and tested only on animals, further comprehensive studies are required to ensure its safety and efficacy for human use.

Mouth Ulcer Treatment Market Segmentation:

Breakup by Formulation:

  • Gel
  • Spray
  • Mouthwash
  • Lozenges

Gel accounts for the majority of the market share

According to mouth ulcer treatment market report, gel dominate the market due to their fast-acting and targeted relief. Their easy application and ability to form a protective barrier over the ulcer make them highly effective in soothing pain and accelerating healing. Gels often contain active ingredients like antiseptics, pain relievers, and anti-inflammatory agents, providing comprehensive treatment in a single application. Their ability to stay localized at the site of the ulcer allows for longer-lasting relief compared to other forms, such as mouthwashes or lozenges. This convenience and effectiveness have led to their widespread preference among consumers.

Breakup by Drug Class:

  • Corticosteroids
  • Anesthetics
  • Analgesics
  • Antimicrobials
  • Antihistamines

Corticosteroids holds the largest share of the industry

Corticosteroids hold the largest share of the mouth ulcer treatment industry due to their powerful anti-inflammatory and immunosuppressive properties. These medications effectively reduce swelling, pain, and irritation associated with mouth ulcers, promoting faster healing. Corticosteroids are often prescribed for severe or recurrent cases of ulcers, such as aphthous stomatitis, where over-the-counter treatments may be less effective. Their ability to target the underlying inflammation makes them a preferred choice among healthcare professionals. Additionally, advancements in topical corticosteroid formulations, like gels and ointments, have improved patient compliance by offering localized relief with minimal systemic side effects. These factors are creating a positive mouth ulcer treatment market outlook, driving the demand for corticosteroid-based products due to their efficacy in managing severe ulcer cases.

Breakup by Indication:

  • Aphthous Stomatitis
  • Oral Lichen Planus
  • Others

Aphthous Stomatitis represents the leading market segment

Aphthous stomatitis, commonly known as canker sores, represents the leading segment in the mouth ulcer treatment market due to its high prevalence among individuals worldwide. This condition is characterized by recurrent, painful ulcers in the mouth, often triggered by stress, injury, or nutritional deficiencies. The demand for effective treatments, such as corticosteroids, gels, and antiseptic mouthwashes, is high as patients seek fast relief from discomfort and accelerated healing. The chronic and recurrent nature of aphthous stomatitis drives the consistent demand for both over-the-counter and prescription treatments. The mouth ulcer treatment market dynamics are further influenced by the need for innovative and accessible solutions to manage the chronic and recurrent nature of aphthous stomatitis, leading to continuous advancements in treatment options and increased competition among pharmaceutical companies. According to an article published in May 2023 by National Library of Medicine, approximately 25% of the global population is affected by recurrent aphthous stomatitis (RAS), a common oral mucosal disease. Factors such as genetics, nutritional deficiencies, stress, and immune dysfunction contribute to the condition. This high prevalence underscores the significant demand for effective treatments and preventive solutions in the market. As a result, pharmaceutical companies are focusing on developing targeted therapies that address the underlying causes of RAS while minimizing recurrence and improving patient outcomes.

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

North America leads the market, accounting for the largest mouth ulcer treatment market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Middle East and Africa, Latin America. According to the report, North America represents the largest regional market for mouth ulcer treatment.

North America leads the global mouth ulcer treatment market, accounting for the largest share due to the region's high awareness of oral health and access to advanced healthcare services. The prevalence of conditions like aphthous stomatitis and other oral ulcers is significant, driving the demand for both over-the-counter and prescription treatments. The region's well-established pharmaceutical industry supports the development and availability of effective treatments, such as corticosteroids, gels, and mouthwashes. Additionally, the focus on research and innovation, along with favorable healthcare reimbursement policies, boosts market growth. The increasing preference for fast-acting, pain-relief products further strengthens North America's leadership in this market. According to mouth ulcer treatment market forecast, North America is expected to continue to lead, with steady growth driven by ongoing advancements in treatment options, rising demand for innovative therapies, and increasing awareness of oral health management. For instance, in November 2023, MidAmerica Pharmaceuticals introduced Kourzeq(TM), a new FDA-approved dental paste for treating canker sores. The paste, containing triamcinolone acetonide, is designed to provide temporary relief and adjunctive treatment for oral inflammatory and ulcerative lesions. Available exclusively through telehealth via BeyondMD, Kourzeq aims to make a positive impact on those suffering from canker sores.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the mouth ulcer treatment industry include Blistex Inc, Church & Dwight Co. Inc., 3M Company, Colgate-Palmolive Company, GSK plc., Bristol-Myers Squibb Company, and Pfizer Inc.
  • The mouth ulcer treatment market is highly competitive, driven by the rising prevalence of oral conditions and an increased focus on self-care. Various treatment options, including topical gels, mouthwashes, and oral medications, cater to different types of ulcers and severity levels. Companies are focused on innovation, offering fast-acting and long-lasting solutions. The market is also witnessing an increasing demand for natural and herbal products as consumers become more health conscious. Price sensitivity, product effectiveness, and accessibility are key factors influencing consumer choice in this evolving market. The mouth ulcer treatment market growth rate is being accelerated by innovations in fast-acting treatments, the rising demand for natural products, and an increased consumer focus on self-care.

Key Questions Answered in This Report:

  • How has the global mouth ulcer treatment market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global mouth ulcer treatment market?
  • What is the impact of each driver, restraint, and opportunity on the global mouth ulcer treatment market?
  • What are the key regional markets?
  • Which countries represent the most attractive mouth ulcer treatment market?
  • What is the breakup of the market based on the formulation?
  • Which is the most attractive formulation in the mouth ulcer treatment market?
  • What is the breakup of the market based on the drug class?
  • Which is the most attractive drug class in the mouth ulcer treatment market?
  • What is the breakup of the market based on the indication?
  • Which is the most attractive indication in the mouth ulcer treatment market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global mouth ulcer treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Mouth Ulcer Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Formulation
  • 5.5 Market Breakup by Drug Class
  • 5.6 Market Breakup by Indication
  • 5.7 Market Breakup by Region
  • 5.8 Market Forecast
  • 5.9 SWOT Analysis
    • 5.9.1 Overview
    • 5.9.2 Strengths
    • 5.9.3 Weaknesses
    • 5.9.4 Opportunities
    • 5.9.5 Threats
  • 5.10 Value Chain Analysis
    • 5.10.1 Raw Material Procurement
    • 5.10.2 Manufacturing
    • 5.10.3 Marketing
    • 5.10.4 Distribution
    • 5.10.5 Retail
    • 5.10.6 End-Use
  • 5.11 Porters Five Forces Analysis
    • 5.11.1 Overview
    • 5.11.2 Bargaining Power of Buyers
    • 5.11.3 Bargaining Power of Suppliers
    • 5.11.4 Degree of Competition
    • 5.11.5 Threat of New Entrants
    • 5.11.6 Threat of Substitutes

6 Market Breakup by Formulation

  • 6.1 Gel
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Spray
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Mouthwash
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Lozenges
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Drug Class

  • 7.1 Corticosteroids
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Anesthetics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Analgesics
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Antimicrobials
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Antihistamines
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Indication

  • 8.1 Aphthous Stomatitis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oral Lichen Planus
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Middle East and Africa
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Latin America
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Competitive Landscape

  • 10.1 Market Structure
  • 10.2 Key Players
  • 10.3 Profiles of Key Players
    • 10.3.1 Blistex Inc.
    • 10.3.2 Church & Dwight Co., Inc.
    • 10.3.3 3M Company
    • 10.3.4 Colgate- Palmolive Company
    • 10.3.5 GSK plc.
    • 10.3.6 Bristol-Myers Squibb Company
    • 10.3.7 Pfizer Inc.